Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

21 International Leprosy Congress - ILC 2022: A Report on the Conference.

Suneetha S, Rao NP. Indian dermatology online journal. 2023; 14 (3) : 454-456.
Download PDF
Publication

Mycobacterium leprae's Infective Capacity Is Associated with Activation of Genes Involved in PGL-I Biosynthesis in a Schwann Cells Infection Model.

Chavarro-Portillo B, Soto C, Guerrero M. International journal of molecular sciences. 2023; 24 (10) : 1-18.
Download PDF
Publication

Effectiveness and safety of multidrug therapy containing clofazimine for paucibacillary leprosy and clarithromycin for rifampicin-resistant leprosy: a systematic review and meta-analysis.

Montezuma T, Vernal S, Andrade E, et al. Frontiers in medicine. 2023;
Download PDF
Publication

High-resolution ultrasonography for early diagnosis of neural impairment in seropositive leprosy household contacts.

Luppi A, Ferreira G, Prudêncio D, et al. PloS one. 2023; 18 (5) : 1-16.
Download PDF
Publication

Bacterial, fungal and parasitic co-infections in leprosy: A scoping review

Fróes LAR, Toma TS, Jachiet M, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2023; 17 (5) : 1-18.
Download PDF
Publication

DYSREGULATED ILC3S-ILCREGS AXIS IN TYPE 1 REACTIONS (T1R) OF LEPROSY

Saini C, Sapra L, Bhardwaj A, et al. Elsevier BV. International Journal of Infectious Diseases. 2023;
Download PDF
Publication

Sistema inteligente para apoio ao diagnóstico de câncer de pele e hanseníase usando análise digital de imagens e redes neurais artificiais profundas

Gomes de Lim P. V. S.. Universidade Federal de Pernambuco. Engenharia Biomédica do Centro de Tecnologia e Geociências. 2023;
Download PDF
Publication

Perfil epidemiológico da Hanseníase no Brasil entre 2017 e 2022

Alves APDF, De Oliveira Filho JEL, Gouveia ADDM, et al. South Florida Publishing LLC. Brazilian Journal of Development. 2023; 9 (05) : 15743-15753.
Download PDF
Publication

Perfil epidemiológico dos pacientes com hanseníase em uma Unidade Básica de Saúde Maranhense

Silva JVDA, Oliveira Neto ADD, Silva DS, et al. Revista Eletronica Acervo Saude. Revista Eletrônica Acervo Saúde. 2023; 23 (5) : e11892.
Download PDF
Publication

Perfil epidemiológico da hanseníase no município de Lavras da Mangabeira, estado do Ceará, Brasil, nos anos de 2011 a 2020

Firmo JA, Freitas RCD, Queiroga CEGD, et al. Revista Eletronica Acervo Saude. Revista Eletrônica Acervo Saúde. 2023; 23 (5) : 1-10.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 180
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD